Description
The authors explicitly state that while oxidative damage is established as a driver of MS, the underlying molecular redox mechanisms are not well known. This knowledge gap directly impedes the development of successful antioxidative therapies for MS treatment.
Gap type: open_question Source paper: Oxidative and nitrosative damage in multiple sclerosis. (2026, Curr Opin Neurol, PMID:41952414)